Advertisement
Research Article Free access | 10.1172/JCI113792
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06510.
Find articles by Kupper, T. in: JCI | PubMed | Google Scholar
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06510.
Find articles by Lee, F. in: JCI | PubMed | Google Scholar
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06510.
Find articles by Birchall, N. in: JCI | PubMed | Google Scholar
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06510.
Find articles by Clark, S. in: JCI | PubMed | Google Scholar
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06510.
Find articles by Dower, S. in: JCI | PubMed | Google Scholar
Published November 1, 1988 - More info
Cultured human keratinocytes have been shown to produce IL-1 alpha and beta mRNA and protein. IL-1 biological activity has been identified in normal human epidermis; in vitro, most biologically active IL-1 resides in a cell-associated compartment. The potential for autocrine effects of IL-1 on human keratinocytes was assessed by measurement of keratinocyte IL-1 receptors. Both high- and low-affinity cell surface receptors that bound recombinant (r) IL-1 alpha and beta with comparable affinities could be identified on cultured human keratinocytes, using 125I-labeled rIL-1. Chemical crosslinking experiments identified a cell surface molecule of roughly 72,500 Mr that bound 125I-labeled IL-1, similar to the molecular weight of previously described IL-1 receptors on fibroblasts, B cells, and T cells. To assess the biological consequences of keratinocyte IL-1 binding, granulocyte-macrophage colony-stimulating factor (GM-CSF) gene expression was measured. The addition of exogenous rIL-1 alpha led to a dose-dependent increase in the accumulation of GM-CSF mRNA, as measured by a sensitive and specific S1 nuclease assay. This increase in mRNA was reflected in a marked increase in GM-CSF biological activity as measured by proliferation of blast cells from chronic myelogenous leukemia patients. The biological activity was completely inhibitable by an antibody to human rGM-CSF. GM-CSF activates mature neutrophils and macrophages and appears to enhance the efficiency of Langerhans cell antigen presentation to T cells. Release of IL-1 from injured or activated keratinocytes may lead to enhanced epidermal GM-CSF gene expression via an autocrine mechanism, thus enhancing local host defense.
Images.